The many faces of multivisceral transplantation.

PubWeight™: 6.89‹?› | Rank: Top 1%

🔗 View Article (PMC 2655210)

Published in Surg Gynecol Obstet on May 01, 1991

Authors

T E Starzl1, S Todo, A Tzakis, M Alessiani, A Casavilla, K Abu-Elmagd, J J Fung

Author Affiliations

1: Department of Surgery, University of Pittsburgh, Pennsylvania 15213.

Articles citing this

Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

Intestinal transplantation in composite visceral grafts or alone. Ann Surg (1992) 4.96

Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today (1993) 4.29

Outcome analysis of 71 clinical intestinal transplantations. Ann Surg (1995) 2.95

The lost chord: microchimerism and allograft survival. Immunol Today (1996) 2.81

Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation (1992) 2.75

Management of intestinal transplantation in humans. Transplant Proc (1992) 2.62

Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg (1998) 2.31

Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg (1995) 2.25

Three years clinical experience with intestinal transplantation. J Am Coll Surg (1994) 2.20

Graft-versus-host disease after brown Norway-to-Lewis and Lewis-to-Brown Norway rat intestinal transplantation under FK506. Transplantation (1993) 2.14

Logistics and technique for combined hepatic-intestinal retrieval. Ann Surg (1992) 1.85

The saga of liver replacement, with particular reference to the reciprocal influence of liver and kidney transplantation (1955-1967). J Am Coll Surg (2002) 1.81

Small intestinal transplantation in humans with or without the colon. Transplantation (1994) 1.74

Transplantation tolerance, microchimerism, and the two-way paradigm. Theor Med Bioeth (1998) 1.67

Piggyback orthotopic intestinal transplantation. Surg Gynecol Obstet (1993) 1.55

Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both. Transplantation (2000) 1.53

Morphological monitoring of human small bowel allografts. Transplant Proc (1993) 1.52

Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg (2001) 1.44

Intestinal transplantation at the University of Pittsburgh. Transplant Proc (1994) 1.42

Abdominal multivisceral transplantation. Transplantation (1995) 1.37

100 multivisceral transplants at a single center. Ann Surg (2005) 1.34

Small bowel and liver/small bowel transplantation in children. Semin Pediatr Surg (1993) 1.30

Current status of intestinal transplantation in children. J Pediatr Surg (1998) 1.28

Clinical small bowel or small bowel plus liver transplantation under FK 506. Transplant Proc (1991) 1.24

Clinical intestinal transplantation: focus on complications. Transplant Proc (1992) 1.11

Graft-versus-host disease after liver and small bowel transplantation in a child. Clin Transplant (1997) 1.09

Intestinal transplantation in children under FK 506 immunosuppression. J Pediatr Surg (1993) 1.02

Acquired immunologic tolerance: with particular reference to transplantation. Immunol Res (2007) 0.97

Intestinal transplantation in humans under FK 506. Transplant Proc (1993) 0.90

Intestinal transplantation and bacterial overgrowth in humans. Transplant Proc (1994) 0.90

Endorectal pull-through of transplanted colon as part of intestinal transplantation. Surgery (1995) 0.88

Logistics and technique for procurement of intestinal, pancreatic, and hepatic grafts from the same donor. Ann Surg (2000) 0.84

Recent advances in hepatic transplantation at the University of Pittsburgh. Clin Transpl (1993) 0.83

Infectious complications after human small bowel transplantation. Transplant Proc (1992) 0.82

The efficacy of daclizumab for intestinal transplantation: preliminary report. Transplant Proc (2000) 0.82

Pancreatic transplantation at the University of Pittsburgh. Clin Transpl (2004) 0.81

Where are we at with short bowel syndrome and small bowel transplant. World J Transplant (2012) 0.80

Functional changes in nonadrenergic, noncholinergic inhibitory neurons in ileal circular smooth muscle after small bowel transplantation in rats. Dig Dis Sci (1998) 0.80

Mesenchymal stem cell therapy in patients with small bowel transplantation: single center experience. World J Gastroenterol (2014) 0.78

Intestinal transplantation. Annu Rev Med (1994) 0.78

Current status of intestinal transplantation. Adv Surg (1994) 0.78

Combined en bloc liver/pancreas transplantation in two different patients. World J Gastroenterol (2009) 0.78

The two-way paradigm of transplantation immunology. Clin Immunol Immunopathol (1996) 0.78

Intestinal transplantation for patients with short gut syndrome and hypercoagulable states. Transplant Proc (2000) 0.78

Hepatic and intestinal transplantation at the University of Pittsburgh. Clin Transpl (1998) 0.78

Lymphocyte trafficking using in situ hybridization and physioanatomy of the intestinal immune system after human small bowel transplantation. Transplant Proc (1992) 0.78

Clinical intestinal transplantation: experience in Miami. Transplant Proc (1997) 0.77

Clinical intestinal transplantation in 1998: Pittsburgh experience. Acta Gastroenterol Belg (1999) 0.77

Allogeneic hematolymphoid microchimerism and prevention of autoimmune disease in the rat. A relationship between allo- and autoimmunity. J Clin Invest (1996) 0.77

Modified technique for combined liver-small bowel transplantation in pigs. World J Gastroenterol (2003) 0.77

Hepatic transplantation at the University of Pittsburgh: new horizons and paradigms after 30 years of experience. Clin Transpl (1994) 0.76

Isolated intestinal versus composite visceral allografts: causes of graft failure. Transplant Proc (2000) 0.76

Chimerism after organ transplantation. Curr Opin Nephrol Hypertens (1997) 0.76

The current status of hepatic transplantation at the University of Pittsburgh. Clin Transpl (1995) 0.76

The transplantation of gastrointestinal organs. Gastroenterology (1993) 0.75

Basic considerations for the procurement of intestinal grafts. Transplant Proc (1994) 0.75

Multivisceral and small bowel transplantation at shiraz organ transplant center. Int J Organ Transplant Med (2014) 0.75

The Role of Cell Migration and Chimerism in Organ Transplant Acceptance and Tolerance Induction. Transplant Sci (1993) 0.75

The long-term efficacy of multivisceral transplantation. Transplant Proc (2000) 0.75

Successful combined liver and small intestine transplantation for short-gut syndrome and liver failure. West J Med (1993) 0.75

Auxiliary en-bloc liver-small bowel transplantation with partial pancreas preservation in pigs. World J Gastroenterol (2004) 0.75

Current perspectives of transplantation immunology via the intestine. Transplant Proc (1996) 0.75

Chimerism after Whole Organ Transplant. Guthrie J Donald Guthrie Found Med Res (1993) 0.75

Abdominal transplantation for unresectable tumors in children: the zooming out principle. Pediatr Surg Int (2015) 0.75

Articles cited by this

A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33

Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg (1989) 5.78

Transplantation of small bowel in the rat: technical and immunological considerations. Surgery (1971) 5.05

Successful small-bowel/liver transplantation. Lancet (1990) 4.85

An improved technique for multiple organ harvesting. Surg Gynecol Obstet (1987) 4.73

Homotransplantation of multiple visceral organs. Am J Surg (1962) 4.28

Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12

Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99

The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84

Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74

Transplantation of multiple abdominal viscera. JAMA (1989) 3.59

Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40

Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18

PHYSIOLOGIC REQUIREMENTS FOR AUXILIARY LIVER HOMOTRANSPLANTATION. Surg Gynecol Obstet (1965) 3.15

Extended preservation of the liver for clinical transplantation. Lancet (1988) 2.89

The use of FK-506 for small intestine allotransplantation. Inhibition of acute rejection and prevention of fatal graft-versus-host disease. Transplantation (1990) 2.79

The Eck fistula in animals and humans. Curr Probl Surg (1983) 2.35

Induction of liver, heart, and multivisceral graft acceptance with a short course of FK 506. Transplant Proc (1990) 2.15

Splanchnic transplantation. An approach to the infant dependent on parenteral nutrition who develops irreversible liver disease. JAMA (1989) 2.10

Prevention of graft-versus-host disease following allogeneic bone marrow transplantation in rats using FK506. Transplantation (1991) 1.95

The influence of portal blood upon lipid metabolism in normal and diabetic dogs and baboons. Surg Gynecol Obstet (1975) 1.91

Use of FK 506 in pediatric patients. Transplant Proc (1991) 1.77

Portal hepatotrophic factors, diabetes mellitus and acute liver atrophy, hypertrophy and regeneration. Surg Gynecol Obstet (1975) 1.74

MASS HOMOTRANSPLANTATION OF ABDOMINAL ORGANS IN DOGS. Surg Forum (1960) 1.74

Successful orthotopic small bowel transplantation with short-term FK 506 immunosuppressive therapy. Transplant Proc (1990) 1.71

The effect of splanchnic viscera removal upon canine liver regeneration. Surg Gynecol Obstet (1978) 1.63

Portal versus caval venous drainage of small bowel allografts: technical and metabolic consequences. Surgery (1986) 1.50

Immunologic and metabolic effects of caval versus portal venous drainage in small-bowel transplantation. Surgery (1988) 1.50

FK 506 reverses acute graft-versus-host disease after allogeneic bone marrow transplantation in rats. Surgery (1991) 1.49

Multivisceral intestinal transplantation: surgical pathology. Pediatr Pathol (1989) 1.45

The effect of diabetes mellitus on portal blood hepatotrophic factors in dogs. Surg Gynecol Obstet (1975) 1.33

Small-bowel transplantation: European experience. Lancet (1990) 1.25

Nutritional and metabolic aspects of total small bowel transplantation in inbred rats. Transplant Proc (1987) 1.19

Small-bowel transplantation in children. Transplant Proc (1990) 1.10

Treatment of upper abdominal malignancies with organ cluster procedures. Clin Transplant (1990) 1.07

Combined small bowel and liver transplantation in the rat: possible role of the liver in preventing intestinal allograft rejection. Transplantation (1991) 1.00

Upper-abdominal exenteration in transplantation for extensive malignancies of the upper abdomen--an update. Transplantation (1991) 1.00

A technique for rapid harvesting of cadaveric renal and pancreatic grafts after circulatory arrest. Br J Surg (1976) 0.92

Visceral interchange. Am J Surg (1989) 0.88

Articles by these authors

FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

Kidney transplantation under FK 506. JAMA (1990) 7.45

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg (1989) 5.78

Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Intestinal transplantation in composite visceral grafts or alone. Ann Surg (1992) 4.96

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29

Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16

Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12

Baboon-to-human liver transplantation. Lancet (1993) 4.01

Liver transplantation in the United States, 1999-2008. Am J Transplant (2010) 3.92

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Transplantation of multiple abdominal viscera. JAMA (1989) 3.59

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. Transplant Proc (1987) 3.55

Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54

IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION. Surg Res Commun (1987) 3.46

Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18

Liver transplantation before 1 year of age. J Pediatr (1987) 3.15

In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs. Transplant Proc (1988) 3.15

The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14

Orthotopic liver transplantation in dogs receiving FK-506. Transplant Proc (1987) 3.11

A multifactorial system for equitable selection of cadaver kidney recipients. JAMA (1987) 3.01

Biliary tract complications in human orthotopic liver transplantation. Transplantation (1987) 2.95

Outcome analysis of 71 clinical intestinal transplantations. Ann Surg (1995) 2.95

Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg (2000) 2.91

Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report. Transplant Proc (1988) 2.87

Equitable allocation of extrarenal organs: with special reference to the liver. Transplant Proc (1988) 2.85

Functional characterization of infiltrating T lymphocytes in human hepatic allografts. Hum Immunol (1986) 2.84

Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. Transplant Proc (1993) 2.81

The use of FK-506 for small intestine allotransplantation. Inhibition of acute rejection and prevention of fatal graft-versus-host disease. Transplantation (1990) 2.79

Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation (1992) 2.75

THE IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 IN RATS RECEIVING HETEROTOPIC CARDIAC ALLOGRAFTS. Surg Res Commun (1987) 2.75

The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med (1995) 2.68

Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506. Lancet (1990) 2.66

Management of intestinal transplantation in humans. Transplant Proc (1992) 2.62

Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations. Transplant Proc (1990) 2.60

Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy. Transplantation (1990) 2.59

Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506. Transplant Proc (1991) 2.59

The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology (1997) 2.57

FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation (1994) 2.50

Pregnancy after liver transplantation under tacrolimus. Transplantation (1997) 2.50

A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine. Transplant Proc (1991) 2.49

Pharmacokinetics of FK 506: preclinical and clinical studies. Transplant Proc (1990) 2.48

Upper abdominal exenteration with liver replacement: a modification of the "cluster" procedure. Transplant Proc (1990) 2.40

Hepatotrophic effects of FK506 in dogs. Transplantation (1991) 2.39

Liver transplantation across ABO blood groups. Surgery (1986) 2.39